Effect of Prontosan Wound Irrigation Solution on Venous Ulcers
Completed · Not applicable
Conditions studied: Wound Care, Venous Ulcer Care, Wound Cleansing, Chronic Wound Care
In brief
Objective: To evaluate the efficacy and safety of Prontosan® Wound Irrigation Solution in the treatment of hard-to-heal venous leg ulcers compared to wound irrigation with saline solution Methodology: Randomised, controlled multi-centre, prospective clinical trial Planned number of subjects: 20 patients in experimental group (Prontosan® Wound Irrigation Solution) 8 patients in control group (wound irrigation with saline) Products under investigation: Prontosan® Wound Irrigation Solution Study Duration: 3-4 weeks
Key facts
- Study ID
- NCT01048307
- Run by
- Calvary Hospital, Bronx, NY
- People needed
- 20
- Starts
- 2009-06-01
- Expected to finish
- 2010-07-01
- Last updated by the study team
- 2010-08-17
Who can join
Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- males and females aged at least 18 with wounds of venous aetiology (documented by targeted exams) located in the lower limbs
- Ankle Brachial Index (ABI) ≥ 0.7
- patients who have not had an antimicrobial (systemic antibiotic or topical antiseptic) over the 30 days before joining the study
You may not qualify if…
- Exclusion criteria
- age below 18 years
- presence of clinical infection, or current use of antiseptics or antibiotics
- chronic wounds of long duration (>30cm2 and >1 year duration)
- involvement in other wound related trials within the past 30 days
- sensitivity to any of the components of Prontosan® or dressing material
- intolerance to compression therapy
- active osteomyelitis in the ulceration area
- active rheumatoid arthritis (RA) requiring any immunosuppressive therapy
- collagen vascular disease active treated with steroids
- chronic diseases that could impact the course of the study (malicious cancer, TB, AIDS, mental illnesses)
- plasma protein below 4 g/dl
- anaemia: haemoglobin below 10 g/dl
- both, controlled and uncontrolled diabetics (type 1 or 2)
- patients on any rheological agents (not including aspirin)
Where it is running
- Calvary hospital center for curative and palliative wound care — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.